tiprankstipranks

Donald A Bergstrom Insider Profile

4 Followers
Donald A Bergstrom, President, R&D at Relay Therapeutics, holds 399.13K shares in Relay Therapeutics (Ticker: RLAY), holds ― shares in Fusion Pharmaceuticals (Ticker: FUSN), holds ― shares in Mersana Therapeutics (Ticker: MRSN).
tipranks
Donald A Bergstrom

Donald A Bergstrom
Relay Therapeutics (RLAY)
President, R&D

Ranked #101,755 out of 109,030 Corporate Insiders

Profitable Transactions

71%
22 out of 31 Profitable Transactions

Average Return

-20.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
100.00%
A breakdown of Donald A Bergstrom's holdings

Insider Roles

Relay Therapeutics
(RLAY)
President, R&D
Roles that Donald A Bergstrom holds in companies

Most Profitable Insider Trade

Stock:
Relay Therapeutics
(RLAY)
Rating:Informative Sell
Date:Mar 29, 2024 - Mar 29, 2025
Return:+67.20%
The most profitable trade made by Donald A Bergstrom

Donald A Bergstrom's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Relay Therapeutics
Sep 09, 2026
President, R&D
Uninformative Sell
161.81K
$7.53M
FUSN
Fusion Pharmaceuticals
MRSN
Mersana Therapeutics
List of latest transactions for each holding click on a transaction to see Donald A Bergstrom's performance on stock

Donald A Bergstrom insider profile FAQ

What is the percentage of profitable transactions made by Donald A Bergstrom?
The percentage of profitable transactions made by Donald A Bergstrom is 71%.
    What is the average return per transaction made by Donald A Bergstrom?
    The average return per transaction made by Donald A Bergstrom is -20.40%.
      What stocks does Donald A Bergstrom hold?
      Donald A Bergstrom holds: RLAY, FUSN, MRSN stocks.
        What was Donald A Bergstrom’s latest transaction?
        Donald A Bergstrom latest transaction was an Uninformative Sell of $161.81K.
          What was Donald A Bergstrom's most profitable transaction?
          Donald A Bergstrom’s most profitable transaction was an Informative Sell of RLAY stock on March 29, 2024. The return on the trade was 67.20%.
            What is Donald A Bergstrom's role in Relay Therapeutics?
            Donald A Bergstrom's role in Relay Therapeutics is President, R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.